Friday, January 30, 2026
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

April 2020 CPD: Sleep Disorders

Natalie by Natalie
25 May 2020
in 2020 Digital Magazines
0
April 2020 CPD: Sleep Disorders
Previous Post

IPHA Launches Latest COVID-19 Industry Response Video Focused on Partnerships and Supports

Next Post

MINAMI® MorEPA Platinum + Vitamin D3

Next Post

MINAMI® MorEPA Platinum + Vitamin D3

Revive Active highlights simple, sustainable approaches to supporting energy and immune health

New Year, No Pressure: Simple Ways to Support Energy and Immunity

28 January 2026
ALONE Urges Government to Reconsider Pharmacy Changes Including Blister Packs

ALONE Urges Government to Reconsider Pharmacy Changes Including Blister Packs

16 December 2025
Migraine Ireland launches the Irish Headache Society to advance migraine and headache care in Ireland.

Migraine Ireland Launches First Multidisciplinary Irish Headache Society

8 December 2025

RECOMMENDED NEWS

Irish Pharmacists prepare for Falsified Medicines Directive compliance deadline in February 2019

7 years ago
Oncologist warns Covid disruption to diagnosis and treatment could increase cancer mortality for “next decade”

Oncologist warns Covid disruption to diagnosis and treatment could increase cancer mortality for “next decade”

5 years ago
What is Endometriosis?

What is Endometriosis?

2 years ago
Erleada®▼(apalutamide) approved for reimbursement in Ireland for the Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Erleada®▼(apalutamide) approved for reimbursement in Ireland for the Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

3 years ago

test-sponsored-ad-jan-2026

Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN